Advertisement

Index by Author

May 1996; 45 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Araki, S

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  2. Atkinson, A B

    • Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects. Diabetes May 1996 45:683-686; doi:10.2337/diabetes.45.5.683

  3. Avogaro, A

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

B

  1. Barone, M

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  2. Basdevant, A

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  3. Bell, P M

    • Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects. Diabetes May 1996 45:683-686; doi:10.2337/diabetes.45.5.683

  4. Berggren, P O

    • A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes May 1996 45:580-586; doi:10.2337/diabetes.45.5.580

  5. Birch, K A

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  6. Björntorp, P

    • Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes May 1996 45:615-621; doi:10.2337/diabetes.45.5.615

  7. Blangero, J

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  8. Boden, G

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

  9. Bogardus, C

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  10. Brothers, J

    • Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes May 1996 45:695-698; doi:10.2337/diabetes.45.5.695

  11. Brown, L J

    • Mitochondrial FAD-glycerophosphate dehydrogenase and G-protein-coupled inwardly rectifying K+ channel: No evidence for linkage in maturity-onset diabetes of the young or NIDDM. Diabetes May 1996 45:639-641; doi:10.2337/diabetes.45.5.639

  12. Bugawan, T L

    • Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes May 1996 45:610-614; doi:10.2337/diabetes.45.5.610

C

  1. Calabrò, A

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  2. Campbell, L V

    • Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes May 1996 45:633-638; doi:10.2337/diabetes.45.5.633

  3. Cardon, L R

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  4. Carey, A

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  5. Carey, D G

    • Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes May 1996 45:633-638; doi:10.2337/diabetes.45.5.633

  6. Caro, J F

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

  7. Cather, C

    • Extreme obesity may be linked to markers flanking the human OB gene. Diabetes May 1996 45:691-694; doi:10.2337/diabetes.45.5.691

  8. Chang, J D

    • Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes May 1996 45:610-614; doi:10.2337/diabetes.45.5.610

  9. Cheng, C

    • Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia. Diabetes May 1996 45:627-632; doi:10.2337/diabetes.45.5.627

  10. Chisholm, D J

    • Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes May 1996 45:633-638; doi:10.2337/diabetes.45.5.633

  11. Clement, K

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  12. Cohen, N

    • Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes May 1996 45:659-666; doi:10.2337/diabetes.45.5.659

  13. Considine, R V

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

  14. Crepaldi, C

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  15. Crepaldi, G

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

D

  1. Dagogo-Jack, S

    • Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes May 1996 45:695-698; doi:10.2337/diabetes.45.5.695

  2. Dammerman, M

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  3. David, G B

    • Islets of Langerhans generate wavelike electric activity modulated by glucose concentration. Diabetes May 1996 45:595-601; doi:10.2337/diabetes.45.5.595

  4. Dell, C

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  5. Demenais, F

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  6. Ding, Y

    • Extreme obesity may be linked to markers flanking the human OB gene. Diabetes May 1996 45:691-694; doi:10.2337/diabetes.45.5.691

E

  1. Ellerman, K E

    • Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes May 1996 45:557-562; doi:10.2337/diabetes.45.5.557

  2. Engerman, R L

    • Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes May 1996 45:587-594; doi:10.2337/diabetes.45.5.587

  3. Ennis, C N

    • Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects. Diabetes May 1996 45:683-686; doi:10.2337/diabetes.45.5.683

  4. Erlich, H A

    • Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes May 1996 45:610-614; doi:10.2337/diabetes.45.5.610

F

  1. Fanelli, C

    • Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes May 1996 45:695-698; doi:10.2337/diabetes.45.5.695

  2. Fischer, U

    • Increased urea synthesis in insulin-dependent diabetic dogs maintained normoglycemic: effect of portal insulin administration and food protein content. Diabetes May 1996 45:667-674; doi:10.2337/diabetes.45.5.667

  3. Flier, J S

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  4. Fogarty, J

    • Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes May 1996 45:587-594; doi:10.2337/diabetes.45.5.587

  5. Frazier, M L

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  6. Freund, J

    • Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes May 1996 45:633-638; doi:10.2337/diabetes.45.5.633

  7. Freyse, E J

    • Increased urea synthesis in insulin-dependent diabetic dogs maintained normoglycemic: effect of portal insulin administration and food protein content. Diabetes May 1996 45:667-674; doi:10.2337/diabetes.45.5.667

  8. Froguel, P

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

G

  1. Gabbay, K H

    • The search for IDDM susceptibility genes: the next generation. Diabetes May 1996 45:544-551; doi:10.2337/diabetes.45.5.544

  2. Garner, C

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  3. Green, E D

    • Extreme obesity may be linked to markers flanking the human OB gene. Diabetes May 1996 45:691-694; doi:10.2337/diabetes.45.5.691

  4. Grill, V

    • A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes May 1996 45:580-586; doi:10.2337/diabetes.45.5.580

  5. Grossman, E B

    • Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes May 1996 45:569-575; doi:10.2337/diabetes.45.5.569

  6. Guberski, D L

    • Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes May 1996 45:557-562; doi:10.2337/diabetes.45.5.557

  7. Gumbiner, B

    • Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes May 1996 45:569-575; doi:10.2337/diabetes.45.5.569

  8. Guy-Grand, B

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

H

  1. Hager, J

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  2. Halberstam, M

    • Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes May 1996 45:659-666; doi:10.2337/diabetes.45.5.659

  3. Harrison, C R

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  4. Harris, T J

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  5. Heath, W F

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  6. Henry, R

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

  7. Hermeling, R N

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  8. Holmäng, A

    • Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes May 1996 45:615-621; doi:10.2337/diabetes.45.5.615

  9. Holst, J J

    • The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones. Diabetes May 1996 45:552-556; doi:10.2337/diabetes.45.5.552

  10. Hunter, S J

    • Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects. Diabetes May 1996 45:683-686; doi:10.2337/diabetes.45.5.683

J

  1. Jenkins, A B

    • Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes May 1996 45:633-638; doi:10.2337/diabetes.45.5.633

  2. Johnston, C M

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  3. Jury, C

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

K

  1. Kern, T S

    • Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes May 1996 45:587-594; doi:10.2337/diabetes.45.5.587

  2. Kim, J K

    • Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats. Diabetes May 1996 45:651-658; doi:10.2337/diabetes.45.5.651

  3. Kishimoto-Hashirmoto, M

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  4. Klitz, W

    • Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes May 1996 45:610-614; doi:10.2337/diabetes.45.5.610

  5. Kobayashi, T

    • Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes May 1996 45:622-626; doi:10.2337/diabetes.45.5.622

  6. Kolaczynski, J W

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

  7. Kosaka, K

    • Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes May 1996 45:622-626; doi:10.2337/diabetes.45.5.622

  8. Krammerer, C M

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

L

  1. Lachov, E

    • Islets of Langerhans generate wavelike electric activity modulated by glucose concentration. Diabetes May 1996 45:595-601; doi:10.2337/diabetes.45.5.595

  2. Landt, M

    • Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes May 1996 45:695-698; doi:10.2337/diabetes.45.5.695

  3. LeDuc, C

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  4. Like, A A

    • Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes May 1996 45:557-562; doi:10.2337/diabetes.45.5.557

  5. Lönnroth, P

    • Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes May 1996 45:615-621; doi:10.2337/diabetes.45.5.615

  6. Low, C C

    • Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes May 1996 45:569-575; doi:10.2337/diabetes.45.5.569

  7. Ludwig, D S

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

M

  1. MacCluer, J W

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  2. Macdonald, I

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  3. MacDonald, M J

    • Mitochondrial FAD-glycerophosphate dehydrogenase and G-protein-coupled inwardly rectifying K+ channel: No evidence for linkage in maturity-onset diabetes of the young or NIDDM. Diabetes May 1996 45:639-641; doi:10.2337/diabetes.45.5.639

  4. Madsbad, S

    • The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones. Diabetes May 1996 45:552-556; doi:10.2337/diabetes.45.5.552

  5. Maffei, M

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  6. Majithia, H R

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  7. Masugi, J

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  8. Mida, Y H

    • Islets of Langerhans generate wavelike electric activity modulated by glucose concentration. Diabetes May 1996 45:595-601; doi:10.2337/diabetes.45.5.595

  9. Milan, D

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  10. Mitchell, B D

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  11. Monnier, V M

    • Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes May 1996 45:587-594; doi:10.2337/diabetes.45.5.587

  12. Moon, B

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  13. Mori, H

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  14. Mudaliar, S R

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

  15. Murase, T

    • Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes May 1996 45:622-626; doi:10.2337/diabetes.45.5.622

N

  1. Nagaraj, R H

    • Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes May 1996 45:587-594; doi:10.2337/diabetes.45.5.587

  2. Nakanishi, K

    • Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes May 1996 45:622-626; doi:10.2337/diabetes.45.5.622

  3. Niki, T

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  4. Nolan, J J

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

  5. North, M

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  6. Nyce, M R

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

O

  1. O'Connell, P

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  2. Olefsky, J

    • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes May 1996 45:699-701; doi:10.2337/diabetes.45.5.699

  3. Owerbach, D

    • The search for IDDM susceptibility genes: the next generation. Diabetes May 1996 45:544-551; doi:10.2337/diabetes.45.5.544

P

  1. Palti, Y

    • Islets of Langerhans generate wavelike electric activity modulated by glucose concentration. Diabetes May 1996 45:595-601; doi:10.2337/diabetes.45.5.595

  2. Paramore, D

    • Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes May 1996 45:695-698; doi:10.2337/diabetes.45.5.695

  3. Pavan, P

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  4. Perry, I J

    • Hematocrit and risk of NIDDM. Diabetes May 1996 45:576-579; doi:10.2337/diabetes.45.5.576

  5. Petrzika, M

    • Increased urea synthesis in insulin-dependent diabetic dogs maintained normoglycemic: effect of portal insulin administration and food protein content. Diabetes May 1996 45:667-674; doi:10.2337/diabetes.45.5.667

  6. Philippi, A

    • Indication for linkage of the human OB gene region with extreme obesity. Diabetes May 1996 45:687-690; doi:10.2337/diabetes.45.5.687

  7. Piarulli, F

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  8. Price, R A

    • Extreme obesity may be linked to markers flanking the human OB gene. Diabetes May 1996 45:691-694; doi:10.2337/diabetes.45.5.691

R

  1. Raffel, L J

    • Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes May 1996 45:610-614; doi:10.2337/diabetes.45.5.610

  2. Rais, N

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  3. Ravussin, E

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  4. Rebrin, K

    • Increased urea synthesis in insulin-dependent diabetic dogs maintained normoglycemic: effect of portal insulin administration and food protein content. Diabetes May 1996 45:667-674; doi:10.2337/diabetes.45.5.667

  5. Reed, D R

    • Extreme obesity may be linked to markers flanking the human OB gene. Diabetes May 1996 45:691-694; doi:10.2337/diabetes.45.5.691

  6. Reifel-Miller, A

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  7. Reinhart, L

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  8. Richards, C A

    • Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes May 1996 45:557-562; doi:10.2337/diabetes.45.5.557

  9. Rincon, J

    • Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes May 1996 45:615-621; doi:10.2337/diabetes.45.5.615

  10. Rossetti, L

    • Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes May 1996 45:659-666; doi:10.2337/diabetes.45.5.659

  11. Rotter, J I

    • Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes May 1996 45:610-614; doi:10.2337/diabetes.45.5.610

S

  1. Sacerdoti, D

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  2. Saker, P J

    • Mitochondrial FAD-glycerophosphate dehydrogenase and G-protein-coupled inwardly rectifying K+ channel: No evidence for linkage in maturity-onset diabetes of the young or NIDDM. Diabetes May 1996 45:639-641; doi:10.2337/diabetes.45.5.639

  3. Sawant, N

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  4. Schatzberger, R

    • Islets of Langerhans generate wavelike electric activity modulated by glucose concentration. Diabetes May 1996 45:595-601; doi:10.2337/diabetes.45.5.595

  5. Schneider, T

    • Increased urea synthesis in insulin-dependent diabetic dogs maintained normoglycemic: effect of portal insulin administration and food protein content. Diabetes May 1996 45:667-674; doi:10.2337/diabetes.45.5.667

  6. Scognamiglio, R

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  7. Sell, D R

    • Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen. Diabetes May 1996 45:587-594; doi:10.2337/diabetes.45.5.587

  8. Shamoon, H

    • Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes May 1996 45:659-666; doi:10.2337/diabetes.45.5.659

  9. Shaper, A G

    • Hematocrit and risk of NIDDM. Diabetes May 1996 45:576-579; doi:10.2337/diabetes.45.5.576

  10. Shaw, S J

    • Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes May 1996 45:610-614; doi:10.2337/diabetes.45.5.610

  11. Shek, W R

    • Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes May 1996 45:557-562; doi:10.2337/diabetes.45.5.557

  12. Sheridan, B

    • Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects. Diabetes May 1996 45:683-686; doi:10.2337/diabetes.45.5.683

  13. Shipman, P A

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  14. Shlimovich, P

    • Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes May 1996 45:659-666; doi:10.2337/diabetes.45.5.659

  15. Smith, C

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  16. Stern, M P

    • Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes May 1996 45:563-568; doi:10.2337/diabetes.45.5.563

  17. Stoffel, M

    • Mitochondrial FAD-glycerophosphate dehydrogenase and G-protein-coupled inwardly rectifying K+ channel: No evidence for linkage in maturity-onset diabetes of the young or NIDDM. Diabetes May 1996 45:639-641; doi:10.2337/diabetes.45.5.639
    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  18. Stramm, L

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  19. Sun, H

    • Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia. Diabetes May 1996 45:627-632; doi:10.2337/diabetes.45.5.627

T

  1. Talley, M

    • Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes May 1996 45:679-682; doi:10.2337/diabetes.45.5.679

  2. Tamori, Y

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

  3. Tiengo, A

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

  4. Toft-Nielson, M

    • The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones. Diabetes May 1996 45:552-556; doi:10.2337/diabetes.45.5.552

  5. Turner, R C

    • Mitochondrial FAD-glycerophosphate dehydrogenase and G-protein-coupled inwardly rectifying K+ channel: No evidence for linkage in maturity-onset diabetes of the young or NIDDM. Diabetes May 1996 45:639-641; doi:10.2337/diabetes.45.5.639

U

  1. Ueno, H

    • Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes May 1996 45:675-678; doi:10.2337/diabetes.45.5.675

V

  1. Valerio, A

    • The hemodynamic abnormalities in short-term insulin deficiency: the role of prostaglandin inhibition. Diabetes May 1996 45:602-609; doi:10.2337/diabetes.45.5.602

W

  1. Wahlström, E O

    • Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes May 1996 45:615-621; doi:10.2337/diabetes.45.5.615

  2. Wallberg-Henriksson, H

    • Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes May 1996 45:615-621; doi:10.2337/diabetes.45.5.615

  3. Wannamethee, S G

    • Hematocrit and risk of NIDDM. Diabetes May 1996 45:576-579; doi:10.2337/diabetes.45.5.576

  4. Warren-Perry, M G

    • Mitochondrial FAD-glycerophosphate dehydrogenase and G-protein-coupled inwardly rectifying K+ channel: No evidence for linkage in maturity-onset diabetes of the young or NIDDM. Diabetes May 1996 45:639-641; doi:10.2337/diabetes.45.5.639

  5. Wi, J K

    • Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats. Diabetes May 1996 45:651-658; doi:10.2337/diabetes.45.5.651

  6. Williamson, J R

    • LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes May 1996 45:642-650; doi:10.2337/diabetes.45.5.642

  7. Wishner, K L

    • 1995 Presidential Address. Things will never be the same again. Diabetes May 1996 45:541-543

X

  1. Xu, W

    • Extreme obesity may be linked to markers flanking the human OB gene. Diabetes May 1996 45:691-694; doi:10.2337/diabetes.45.5.691

Y

  1. Youn, J H

    • Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats. Diabetes May 1996 45:651-658; doi:10.2337/diabetes.45.5.651

Z

  1. Zeidler, A

    • Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes May 1996 45:610-614; doi:10.2337/diabetes.45.5.610

  2. Zhang, Y

    • Mitochondrial FAD-glycerophosphate dehydrogenase and G-protein-coupled inwardly rectifying K+ channel: No evidence for linkage in maturity-onset diabetes of the young or NIDDM. Diabetes May 1996 45:639-641; doi:10.2337/diabetes.45.5.639

  3. Zhou, Y P

    • A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes May 1996 45:580-586; doi:10.2337/diabetes.45.5.580

  4. Zierath, J R

    • Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes May 1996 45:615-621; doi:10.2337/diabetes.45.5.615

  5. Zochodne, D W

    • Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia. Diabetes May 1996 45:627-632; doi:10.2337/diabetes.45.5.627

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement